ArthroCare’s Q3 profits surge

November 2, 2012 By MassDevice staff Leave a Comment

ArthroCare (NSDQ:ARTC) began reaping the rewards of putting an earnings statement imbroglio behind it during the 3rd quarter, posting a whopping 478% profit surge.

The Austin, Texas-based medical device company posted profits of $9.1 million, or 27¢ per share, on sales of $86.9 million during the 3 months ended Sept. 30. That represents a 4.4% increase in sales and 477.9% bottom-line growth.

The major impact on the bottom line came from a $6.3 million reduction in operating expenses related to lower "investigation and restatement-related costs," the company said.

Sign up to get our free newsletters delivered straight to your inbox

A pair of former ArthroCare executives, John Raffle and David Applegate, are accused of inflating the company’s earnings by 10s of millions of dollars through sham transactions with distributors from around December 2005 to December 2008. The scandal forced ArthroCare to restate its financials for those years, and has been a drag on profits ever since the scandal broke in 2008.

The news sent ARTC shares up 6.4% today to a $31.99 close on Wall Street.

Your fitness tracker could be misleading you
Your heart rate may be accurate on your fitness tracker, but the number of calories burned is significantly wrong, according to new research from Stanford University. The researchers suggest that although the heart rate measurements are pretty much accurate, energy expenditure measurements are probably significantly wrong. Apple Watch, Basis Peak, Fitbit Surge, Microsoft Band, Mio […]
Thinking about wading into robotic surgery? We’ve got some advice for you
There are a handful of companies in the robotic surgical space. But that is about to change. There is ample evidence that the robotic surgical device market is going to explode in the next 3 to 5 years. We recently spoke with Todd Pope, CEO of TransEnterix who said there is a lot of opportunity […]
9 diabetes breakthroughs you need to know
Diabetes is a disease that affects the body’s ability to produce and respond to insulin. About 29.1 million people have diabetes in the U.S, according to the Centers for Disease Control and Prevention. Of that number, 8.1 million go undiagnosed. One of the most popular breakthroughs in diabetes research has been the artificial pancreas, which […]
Diba Industries announces patent for multistage syringe assembly
Diba Industries, a leader in precision fluid handling solutions to global OEM leaders in diagnostics, life sciences and medical devices, announced the issuance of a patent by the U.S. Patent Office for a multistage syringe assembly. The patent for the invention, number 9,579,687, is the 6th patent award for Diba Industries. The multi-stage syringe offers 2 […]
Mechanical heart valves are so loud that they cause insomnia
A quarter of patients with mechanical heart valves claim that the valves disturb their sleep, according to a new study. “For some patients, the closing sound of their mechanical heart valve reduces their quality of life, disturbs their sleep, causes them to avoid social situations and leads to depression and anxiety,” said Kjersti Oterhals, a […]
2 paths to success on the medtech fundraising trail
Funding a medical technology company isn’t a simple job: Modern medical devices require cutting-edge innovation, research and design to make it to market. And don’t even get started on regulatory and reimbursement challenges. The recession of the late 2000s, Affordable Care Act and changes to regulatory bodies and reimbursement requirements have changed the game for […]
4 steps to deeper medical device design insights
When it comes to medical device design insights, Karten Design might have a helpful tool with its “Voice of the Ecosystem” approach. There are many changes to the healthcare system, Eunji Park, lead design strategist at Karten Design, explained during a webinar this week entitled, “Unpacking the Ecosystem of Healthcare Consumers.” Cost increases in the healthcare […]
Medtech stories we missed this week: May 26, 2017
From Merck’s new licensing agreement to surgical study data being touted, here are medtech stories we missed this week but thought were still worth mentioning. 1. Merck inks exclusive licensing agreement for Alzheimer’s antibody Merck announced in a May 25 press release that it has entered an exclusive worldwide license agreement with Teijin Pharma. The […]
FDA Commissioner asks staff for ‘more forceful steps’ to stem the opioid crisis
By: Scott Gottlieb, M.D. As Commissioner, my highest initial priority is to take immediate steps to reduce the scope of the epidemic of opioid addiction. I believe the Food and Drug Administration continues to have an important role to play in addressing this crisis, particularly when it comes to reducing the number of new cases […]
ivWatch touts new OEM board for IV infiltration detection
Hampton, Va.-based ivWatch announced the launch of its ivWatch OEM board designed to enable seamless integration of its IV infiltration detection technology with patient monitoring systems, infusion pumps and other devices. OEMs can help bring a higher level of patient care to patients and reduce risks that come from IV therapies by using ivWatch technology […]
Artificial intelligence accurately predicts stroke risk
Machine-learning algorithms, a form of artificial intelligence, accurately predicted people’s risk of heart disease and stroke, according to new research from the University of Nottingham. Researchers and computer scientists compared the risk guidelines for heart disease and stroke from the American College of Cardiology with 4 machine-learning algorithms to analyze the risk of a patient […]